The document summarizes the key points from a quarterly review meeting of India's National AIDS Control Programme. It provides an overview of the program, highlights achievements in reducing HIV infections and AIDS-related deaths, and outlines the vision and targets to end AIDS by 2030. Key agenda items discussed establishing ART centers in all medical colleges, eliminating mother-to-child HIV transmission, implementing the HIV/AIDS Prevention and Control Act of 2017, and achieving the 90-90-90 fast track targets to diagnose and treat people living with HIV. Support was requested from states to help scale up HIV testing, treatment and care.
NACP IV critical analysis , where we have given a brief idea about the burden of HIV/AIDs globally , National and statewise. Evolution of NACO and NACP under different phases. Current achievements and the indicator to monitor the progress
Acquired immunodeficiency syndrome (AIDS) is a chronic, potentially life-threatening condition caused by the human immunodeficiency virus (HIV). By damaging your immune system, HIV interferes with your body's ability to fight infection and disease.
The National AIDS Control Programme (NACP), launched in 1992, is being implemented as a comprehensive programme for prevention and control of HIV/AIDS in India. Over time, the focus has shifted from raising awareness to behavior change, from a national response to a more decentralized response and to increasing involvement of NGOs and networks of PLHIV.
The slides contain a brief review of NACP 1 through 4.
Key achievements and challenges of NACP Phase 4 have been mentioned. Further, Key strategies of national strategic plan for elimination of HIV/AIDS 2017-2024 has been discussed.
NATIONAL AIDS CONTROL PROGRAM
1992- - NACP 1 launched to show down the spread of HIV infection
- national AIDS control board constituted
- NACO setup
1999- - NACP 2 begins focusing on behaviour change , increased decentralization and NGO involvement.
- state AIDS control societies developed .
2002- - national AIDS control policy adopted.
- national blood policy adopted.
2004- - antiretroviral treatment initiated .
2006- - national council on AIDS constituted under chairmanship of prime minister.
- national policy on paediatric ART formulated.
2007- - NACP 3 launched for years (2007-2012)
2012- - NACP 4 launched for next 5 years
NACP IV critical analysis , where we have given a brief idea about the burden of HIV/AIDs globally , National and statewise. Evolution of NACO and NACP under different phases. Current achievements and the indicator to monitor the progress
Acquired immunodeficiency syndrome (AIDS) is a chronic, potentially life-threatening condition caused by the human immunodeficiency virus (HIV). By damaging your immune system, HIV interferes with your body's ability to fight infection and disease.
The National AIDS Control Programme (NACP), launched in 1992, is being implemented as a comprehensive programme for prevention and control of HIV/AIDS in India. Over time, the focus has shifted from raising awareness to behavior change, from a national response to a more decentralized response and to increasing involvement of NGOs and networks of PLHIV.
The slides contain a brief review of NACP 1 through 4.
Key achievements and challenges of NACP Phase 4 have been mentioned. Further, Key strategies of national strategic plan for elimination of HIV/AIDS 2017-2024 has been discussed.
NATIONAL AIDS CONTROL PROGRAM
1992- - NACP 1 launched to show down the spread of HIV infection
- national AIDS control board constituted
- NACO setup
1999- - NACP 2 begins focusing on behaviour change , increased decentralization and NGO involvement.
- state AIDS control societies developed .
2002- - national AIDS control policy adopted.
- national blood policy adopted.
2004- - antiretroviral treatment initiated .
2006- - national council on AIDS constituted under chairmanship of prime minister.
- national policy on paediatric ART formulated.
2007- - NACP 3 launched for years (2007-2012)
2012- - NACP 4 launched for next 5 years
NACP (National AIDS Control Programme) launched on February 12 ,2014. The Objectives was:
- Reduce new infections by 50% (2007 Baseline of NACP III)
- Comprehensive care, support and treatment to all persons living with HIV/AIDS
AIDS and its vengeance saw a back seat after we achieved the zero level of growth for it. But worries regarding the people living with AIDS are still on and we need to take care of these segments in an integrated manner
NACP (National AIDS Control Programme) launched on February 12 ,2014. The Objectives was:
- Reduce new infections by 50% (2007 Baseline of NACP III)
- Comprehensive care, support and treatment to all persons living with HIV/AIDS
AIDS and its vengeance saw a back seat after we achieved the zero level of growth for it. But worries regarding the people living with AIDS are still on and we need to take care of these segments in an integrated manner
NATIONAL AIDS CONTROL PROGRAMME(NACP) PPT BY KRITIKA.pptxKritikaDhawan9
Acquired immunodeficiency syndrome (AIDS) is a chronic , potentially life, threating condition caused by the human immunodeficiency virus(HIV), a human retrovirus . By, damaging your immune system , HIV interferes with your body's ability to fight infection and disease.
HIV uses the machinery of the CD4 cells to multiply and spread throughout the body .
After the successful NSP 2017-2025,Goi is lauching NSP 2017-2025 for elimination of TB on 24th march( World TB day ) 2017. Module is on MOHFW site but i have try to keep it brief,hope its ll be useful specially for academic and administrative purposes.
National health policy, as a document , it has included everything under the health spectrum. But where the policy is lagging behind? whether we are able to achieve the targets or not? These all are explained in the PPT .
Viral Hepatitis Control Programme with Latest additions !!! This presentation has maximum latest additions from GoI programme guidelines . Original ppt has been modified according to local needs . Feel free to share and use with modifications if needed
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
NACO.pptx
1. National AIDS Control Programme
First Quarterly Review Meeting
19th and 20th September 2019
2. Outline
• National AIDS Control Programme at a glance
• Agenda Items
• Vision document
• Fast Track Targets (90-90-90)
• The HIV and AIDS (Prevention and Control) Act, 2017
• Elimination of Mother to Child Transmission (EMTCT) of HIV
• Establishment of Anti-Retroviral Therapy (ART) centres in all Medical
College
• Improving Voluntary Blood Donation (VBD)
4. National AIDS Control Programme: Highlights
• Fully funded “Central Sector Scheme”
• Initiated in 1992
• Currently NACP-IV (Extension) 2017-20 under implementation
• One of the world’s largest and most comprehensive HIV/AIDS
programmes for key populations and PLHIV
• Around 10 million of most at risk population covered through 1404
targeted interventions
• More than 4.5 crore HIV tests in year through 31,377 HIV counselling
and testing facilities
• 14.36 lakh HIV patients on life long free Anti-Retroviral Therapy (ART)
(primarily through central government funding at 1,654 ART and Link
ART Centers)
5. National AIDS Control Programme: Achievements
• Halted and reversed the HIV/AIDS Epidemic
• 80% reduction in new HIV infections since peak in 1995 (Global average of 47%)
• 70% reduction in AIDS related deaths since its peak in 2005 (Global average of 51%)
• From a virtual death sentence to a chronic manageable disease
6. National AIDS Control Programme: Evolution & Progress
NACP I (1992-
1999)
Centralized
approach
Awareness and
Blood Safety
NACP II (1999-
2006)
Decentralization to
states
Prevention,
Counseling and
Testing
Launch of
treatment
services(2004)
NACP III (2007-
2012)
District Focus
Massive scale up
of services with
quality assurance
mechanisms
Universalization
of testing of HIV
among pregnant
women
NACP IV (2012-17)
Consolidate gains
Focus on emerging
vulnerabilities,
Balance prevention
with growing
treatment needs,
Integrate &
Mainstream
NACP-IV Extension
(2017-20)
Committed to make
concrete progress
towards “End of AIDS
by 2030”
Test and Treat;
Mission Sampark
Viral Load Monitoring
HIV/AIDS Act
7. Goals and Targets
End of AIDS epidemic
as Public Health threat
• Reduce new HIV infections by 75% (Baseline 2010)
• Achieve treatment targets of 90-90-90
• Eliminate Mother to Child Transmission of HIV
• Eliminate HIV-related stigma and discrimination
2020
SDG Goal 3,
Target 3.3
2030
Fast Track
Targets
90-90-90 By 2020
90% of all people living with HIV will know their HIV status
90% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy
90% of all people receiving antiretroviral therapy will have viral suppression
8. Global and India HIV/AIDS Epidemic Status
Indicator Global (2018) India (2017)
People living with HIV (All ages) 3.79 crore 21.40 lakh
New HIV Infections (All ages) 17 lakh 88,000
PLHIV on ART 2.33 crore 14.36 lakh*
AIDS-Related Deaths 7.70 lakh 69,000
Low Prevalence Country (0.22%); Concentrated epidemic
3rd Largest No. of PLHIV in the world
Female: 42% of PLHIV; Children: 3% of PLHIV 6.26
3.14
2.69
1.58
0.86
0.51
0.28
IDU
TG
MSM
FSW
Truckers
Migrants
ANC
Source: HIV Estimations 2017, HIV Sentinel Surveillance 2016-17, NACO
HIV Prevalence (%) in different population groups (India)
* As on July 2019
12. Agenda Item 1: Vision document (2019-2024)
Goal: Ending AIDS by 2030
Targets
1. 80% reduction in new HIV infections (against baseline of 2010)
2. Ensuring that 95% of those who are HIV positive in the country know their status, 95% of those
who know their status are on treatment and 95% of those who are on treatment have durable viral
load suppression.
Key performing Indicators (KPI)
Parameter(s) and Unit Quantified Target
15 August 2022 1st year
(2019-20)
2nd year
(2020-21)
3rd year
(2021-22)
4th year
(2022-23)
5th year
(2023-24)
Number of HIV tests
conducted annually (lakhs)
668 450 500 668 783 900
Number of PLHIV on ART
cumulative (lakhs)
18.7* 13.9* 15.3* 18.7* 19.7* 20.3*
Number of PLHIV tested
for Viral Load cumulative
(lakhs)
13 7 11 13 14 16
* Including PLHIV taking ART from private sector
13. Context
• SACS are autonomous societies, but function under an Executive Committee
Chaired by Principal Secretary, Health/Additional Chief Secretary
• Central Sector Scheme, funds routed directly to SACS
• State support is required in the form of
• Deputation of officers to SACS
• Use of health systems for testing and treatment
• Warehouses for drugs/ kits
• Fast tracking of HIV/AIDS Prevention and control (2017) act
• Increasing need for resources from States is envisaged
• HIV Screening Kits at Primary Health Center Level
• Human Resources at ART Center
• Opportunistic infections management
• Social Protection Schemes
15. Agenda Item 2: Fast Track Targets (90-90-90): National Scenario vis-
à-vis global average
Indicator Target (2020) India (2018-19) Global (2018)
Percent PLHIV aware of their HIV Status 90% 79% 79%
Out of PLHIV who know their HIV status, %
PLHIV on ART
90% 82% 78%
Out of PLHIV who are on ART, % PLHIV Virally
Suppressed
90% 78%* 86%
* Refers to April-August 2019
17. Areas of Considerations
• New HIV infections:
• Timely contracting and release of budget to NGO/CBO Led targeted
interventions / Link worker scheme
• Multi-sectoral response (Education, WCD, Social justice & empowerment,
Labor, etc)
• HIV Testing
• Testing Enough
• Testing Right
• Treatment
• ICTC-ART Linkage
• ART Initiation
• ART Retention
• ART Adherence
• Quarterly reviewed with SACS
18. Agenda Item 3: The HIV and AIDS (Prevention and Control) Act, 2017
19. The HIV & AIDS (Prevention & Control) Act, 2017 Evolution
2018
2019
2018
2019
HIV and AIDS (Prevention and Control) Act,
2017 was brought into force
10th September
Central Government Rules (Section 47) were
notified after due assent from MoL&J
17th September
24 States have held state
consultations on HIV and AIDS
Act, 2017
31st May, 2019
15 states have finalised the state rules
2 states have already appointed the Ombudsman
20. The HIV & AIDS (Prevention & Control) Act, 2017
1. Address stigma &
discrimination
2. Create an enabling environment
for enhancing access to services
3. Safeguarding rights of PLHIV &
those affected by HIV
4. Provide free diagnostic facilities
and ART to PLHIVs.
5. Promote safe workplace in
healthcare settings to prevent
occupational exposure
6. Strengthen system of grievance
redressal
Hailed as the most progressive such legislation in the world
Passed by the Parliament in April 2017; Central Rules notified in September 2018
21. State-wise status update on framing of Rules (1)
Status Name of States
Rules Notified Punjab , Chhattisgarh
Ombudsman deputed Himachal Pradesh, Jharkhand
Rules formulated, under approval Goa, Karnataka, Odisha, Haryana, Rajasthan, Madhya Pradesh,
Gujarat, Delhi, Nagaland, Maharashtra
Rules not formulated Uttar Pradesh, Meghalaya, Bihar, Assam, Arunachal Pradesh
Uttarakhand, Andhra Pradesh, Manipur, Mizoram, Sikkim, Tripura,
West Bengal, Jammu and Kashmir, Kerala, Telangana Tamil Nadu, Rest
of UTs
22. Agenda Item 4: Elimination of Mother to Child Transmission (EMTCT)
23. Agenda Item 4: Elimination of Mother to Child Transmission (EMTCT)
• One of the 2020 fast-track targets
• Antenatal care coverage (at least one visit) of > =95%
• Coverage of HIV testing of pregnant women of > =95%
• Antiretroviral treatment coverage of HIV-positive pregnant women of > =95%
41
48
53
58
60
66
67
69
70
70
71
73
80
81
82
82
83
83
90
95
97
99
100
101
105
105
106
114
115
117
118
132
134
Uttar
Pradesh
Daman
&
Diu
Jammu
&…
Arunachal…
Bihar
Madhya
Pradesh
Uttarakhand
Odisha
Assam
Sikkim
Nagaland
Rajasthan
Tripura
Delhi
Chhatisgarh
Haryana
Goa
Meghalaya
Jharkhand
Kerala
Himachal
Pradesh
A
&
N
Islands
Gujarat
Punjab
Manipur
West
Bengal
Tamil
Nadu
Maharashtra
Telangana
Karnataka
Andhra
Pradesh
Chandigarh
Mizoram
% PW Tested for HIV India (77%)
% pregnant women tested for HIV against estimated pregnancies
Uttar Pradesh, Bihar, Madhya Pradesh
Critical to achieve EMTCT
24. Support Required
• Single window access to HIV testing along with other antenatal
testing (Hb, Sugar, Urine, Hepatitis, Syphilis) – mismatch in no of
pregnant women screened for HIV and Syphilis
• Whole blood finger prick tests for community-based HIV
screening of all pregnant women including village health and
nutrition day (VHSND)-
• Training ANM/ Asha for HIV screening at Village Health and
Nutrition Day and linkage of screened reactive for confirmation of
the diagnosis.
• Incentivized referral linkages of positive pregnant women to ARTC
may be funded by States.
25. 15 Priority States Strategy for Prevention of Parents to Child Transmission
(PPTCT)
States PMTCT need [2017]
Maharashtra 2,406
Uttar Pradesh 2,286
Bihar 2,090
Andhra Pradesh 1,960
Karnataka 1,951
Telangana 1,737
West Bengal 1,453
Gujarat 1,297
Tamil Nadu 1,167
Rajasthan 959
Madhya Pradesh 723
Jharkhand 632
Odisha 603
Delhi 533
Haryana 446
Total [15 states] 20,243
India total 22,677
% contribution of 15 states to India total 89.27
• Priority Districts
• Intensified
interventions
• NHM Collaboration
26. Agenda Item 5: Establishment of Anti-Retroviral Therapy (ART) centres
in all Medical College
27. Agenda Item 5: Establishment of Anti-Retroviral Therapy (ART)
• Board of Governors in super-session of Medical Council of India has issued
an amended Gazette notification, dated 25th June 2019, wherein
establishment of ART center is mandatory for all Medical Colleges, which
are functional for more than 4 years
• Around 30 Government and 198 private Medical Colleges are functional for more
than 4 years and do not have an ART center
• For medical college (Government or Private) which do not have an ART
center, NACO to provide drugs and Technical support while HR and
Infrastructure is supported by Institutes
• For medical colleges (Government) where ART center is already functional
with NACO support, Medical Colleges may take over the HR and recurring
cost component of ART centers in phased manner
• For medical colleges (private) where ART center is already functional in PPP
mode, it is proposed to continue to same approach
28. Blood Transfusion Services
• Promoting non- remunerated Voluntary Blood Donation;
screening for HIV and other Transfusion Transmissible
Infection;
• Promoting Component separation
• Strengthening Quality management systems and Capacity
building
• Around 12 million blood units collected in 2018-19
29. Agenda Item 6: Improving Voluntary Blood Donation (VBD)
• National Blood Transfusion Council (NBTC) of India promote 100% voluntary
blood donation in all blood banks across the country
• Revitalizing and Augmenting State Blood Transfusion Council
% Voluntary Blood Donation
30
30
33
36
37
41
47
52
52
57
66
70
70
70
75
76
79
79
80
80
81
83
83
86
87
87
87
88
89
93
94
95
98
99
99
100
Manipur
Puducherry
Nagaland
Meghalaya
Uttar
Pradesh
Delhi
Bihar
Assam
Chhattisgarh
Rajasthan
Telangana
Jammu
&
Kashmir
Jharkhand
Odisha
Goa
India
Kerala
Sikkim
Himachal
Pradesh
Uttarakhand
Tripura
Andhra
Pradesh
Gujarat
West
Bengal
Daman
&
Diu
Madhya
Pradesh
Mizoram
Chandigarh
A
&
N
Islands
Haryana
Punjab
Karnataka
Arunachal
Pradesh
Maharashtra
Tamil
Nadu
Dadra
&
Nagar…
30. Support Required
• State Blood Transfusion Council (SBTC) is set up in all State and UT
under chairpersonship of Prl. Secretary Health, but not optimally
functional.
• Director SBTC to be designated
• State funds allocated for voluntary blood donation
• Setting up of up public sector blood banks in districts without blood
banks
• All NBTC norms and guidelines to be complied with
• Regular meetings of Governing Body of SBTC to be convened (at least
two meetings in a year)
• Observance of World Blood Donation Day and National Voluntary
Blood Donation Day
31. Thank you
2011: Appreciated in UN General Assembly Special Session 2013: India elected the Chair of UNAIDS Board
Wide recognition for supplying ARV medicines
for PLHIV across the world
Over 20 International governmental delegations visited
India; South to South Collaboration